远程皮肤病学中的生活质量测量:EADV 立场声明
欧洲皮肤病与性病学会(EADV)生活质量与患者导向结局工作组及远程皮肤病学工作组联合发布立场声明,阐述远程皮肤病学中健康相关生活质量(HRQoL)评估的现有知识,比较面对面与远程会诊对 HRQoL 影响的差异,并提出实践推荐。声明认为 HRQoL 评估可成为多数远程皮肤病学活动的重要部分,推荐使用 DLQI(含七种语言版本的 DLQI 应用)。
要点
- HRQoL 评估可成为多数远程皮肤病学活动的重要组成部分。
- 远程会诊期间可简便有效地进行 HRQoL 评估。
- 推荐在远程皮肤病学中使用 DLQI,包括七种语言的 DLQI 应用。
核心结论
- HRQoL 评估可成为多数远程皮肤病学活动的重要部分,且可简便有效地在远程会诊期间进行。
- 监测慢性皮肤病患者 HRQoL 在封锁期间或难以到医院面对面就诊的地区尤为重要。
- 远程会诊期间定期评估皮肤病患者 HRQoL 可能有助于监测治疗疗效并可视化患者个体需求。
- 推荐在远程皮肤病学中使用 DLQI,包括使用提供七种语言的 DLQI 应用。
- 为儿童(如 CDLQI 和 InToDermQoL)及疾病特异性工具开发皮肤科特异性 HRQoL 应用很重要。
研究设计与样本
- 由 EADV 生活质量与患者导向结局工作组及 EADV 远程皮肤病学工作组联合组织的立场声明。
关键数值与推荐
- HRQoL 评估可成为多数远程皮肤病学活动的重要部分。
- HRQoL 评估可简便有效地在远程皮肤病学会诊期间进行。
- 推荐在远程皮肤病学中使用 DLQI,包括使用提供七种语言的 DLQI 应用。
- 为儿童开发皮肤科特异性 HRQoL 应用(如 CDLQI 和 InToDermQoL)及疾病特异性工具很重要。
临床怎么用
- 在远程皮肤病学活动中可将 HRQoL 评估作为重要组成部分并简便有效地实施。
- 在封锁期间或面对面就诊困难地区应尤其重视监测慢性皮肤病患者的 HRQoL。
- 远程会诊期间定期评估 HRQoL 可帮助监测治疗疗效并可视化患者个体需求。
- 远程皮肤病学中推荐使用 DLQI,包括七种语言的 DLQI 应用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many events, including the COVID-19 pandemic, have accelerated the implementation of teledermatology pathways within dermatology departments and across healthcare organizations. Quality of Life (QoL) assessment in dermatology is also a rapidly developing field with a gradual shift from theory to practice. The purpose of this paper organized jointly by the European Academy of Dermatology and Venereology (EADV) Task Force (TF) on QoL and patient-oriented outcomes and the EADV TF on teledermatology is to present current knowledge about QoL assessment during the use of teledermatology approaches, including data on health-related (HR) QoL instruments used in teledermatology, comparison of influence of different treatment methods on HRQoL after face-to-face and teledermatology consultations and to make practical recommendations concerning the assessment of QoL in teledermatology. The EADV TFs made the following position statements: HRQoL assessment may be an important part in most of teledermatology activities; HRQoL assessment may be easily and effectively performed during teledermatology consultations. It is especially important to monitor HRQoL of patients with chronic skin diseases during lockdowns or in areas where it is difficult to reach a hospital for face-to-face consultation; regular assessment of HRQoL of patients with skin diseases during teledermatology consultations may help to monitor therapy efficacy and visualize individual patient's needs; we recommend the use of the DLQI in teledermatology, including the use of the DLQI app which is available in seven languages; it is important to develop apps for dermatology-specific HRQoL instruments for use in children (for example the CDLQI and InToDermQoL) and for disease-specific instruments.
引用
- Chernyshov PV, Finlay AY, Tomas-Aragones L, et al. Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology. J Eur Acad Dermatol Venereol. 2023. PMID: 37877648. doi:10.1111/jdv.19570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。